Someone else made the point but it just clicked for me. Last Cap Raise was 1/10/19 and on 19/10/19 MSB entered into agreement with Lonza for manufacturing of Ryoncil in preparation for commercial launch in paediatric GvHD. That was for $75mil in an indication immensely smaller than the current Covid-19 ARDS needs. I wonder if how much of that cap raise was prompted at the request of Lonza. By the same token I wonder if there was any promoting here and if there will be will be a subsequent announcement in 2 weeks announcing an agreement with Lonza for manufacturing Ryoncil in preparation for a commercial launch in ARDS.
Re: Ann: Trading Halt, page-2
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.010(0.91%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $4.794M | 4.399M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14500 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 141676 | 5 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |